George Shenouda, Roberto Diaz, Bassam Abdulkarim, Kevin Petrecca, Scott Peter Owen, Valerie Panet-Raymond, Amro Mohammad, Miguel Barrera, William Davalan, Antoneta Baciu, Tationa Carvalho, Melissa Charbonneau, Marianna Perna, Tanya Kozel, Jeffery Hall, Marie-Christine Guiot, Luis Souhami. "Phase II propensity-matched controlled trial evaluating metformin as an adjunct to neo-adjuvant, concomitant, and adjuvant temozolomide and hypofractionated-accelerated radiotherapy (M-HART) in glioblastoma patients (NCT02780024).." Journal of Clinical Oncology, 2025. doi:10.1200/jco.2025.43.16_suppl.2064